Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
NCT03939481 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1336
Last updated 2026-04-13
Summary
This trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer. Treatments for cancer can cause a problem to the nervous system (called peripheral neuropathy) that can lead to tingling or less feeling in hands and feet. Studying certain risk factors, such as age, gender, pre-existing conditions, and the type of treatment for cancer may help doctors estimate how likely patients are to develop the nerve disorder.
Conditions
- Stage IIA Lung Cancer AJCC v8
- Stage IIA Ovarian Cancer AJCC v8
- Stage IIB Lung Cancer AJCC v8
- Stage IIB Ovarian Cancer AJCC v8
- Stage III Lung Cancer AJCC v8
- Stage III Ovarian Cancer AJCC v8
- Stage IIIA Lung Cancer AJCC v8
- Stage IIIA Ovarian Cancer AJCC v8
- Stage IIIA1 Ovarian Cancer AJCC v8
- Stage IIIA2 Ovarian Cancer AJCC v8
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Lung Non-Small Cell Carcinoma
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIA Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
- Stage I Lung Cancer AJCC v8
- Stage I Ovarian Cancer AJCC v8
- Stage IA Ovarian Cancer AJCC v8
- Stage IA1 Lung Cancer AJCC v8
- Stage IA2 Lung Cancer AJCC v8
- Stage IA3 Lung Cancer AJCC v8
- Stage IB Lung Cancer AJCC v8
- Stage IB Ovarian Cancer AJCC v8
- Stage IC Ovarian Cancer AJCC v8
- Stage II Lung Cancer AJCC v8
- Stage II Ovarian Cancer AJCC v8
- Stage IIIB Lung Cancer AJCC v8
- Stage IIIB Ovarian Cancer AJCC v8
- Stage IIIC Lung Cancer AJCC v8
- Stage IIIC Ovarian Cancer AJCC v8
Interventions
- DRUG
-
Given chemotherapy regimen
- OTHER
-
Functional Assessment
Functional and sensory clinician assessments
- OTHER
-
Questionnaire Administration
Patient and physician reported responses
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
SWOG Cancer Research Network
lead NETWORK
Principal Investigators
-
Meghna S Trivedi · SWOG Cancer Research Network
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-14
- Primary Completion
- 2025-04-08
- Completion
- 2026-09-01
Countries
- United States
- Chile
- Colombia
- Mexico
Study Locations
More Related Trials
-
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer
NCT04205071 ·Status: WITHDRAWN ·Phase: PHASE1
-
Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer
NCT04068090 ·Status: UNKNOWN
-
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
NCT00002900 ·Status: COMPLETED
-
Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
NCT02101385 ·Status: COMPLETED ·Phase: PHASE2
-
Studying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBC
NCT06684054 ·Status: NOT_YET_RECRUITING
-
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients
NCT05889988 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Neoadjuvant Chemotherapy of Breast Cancer
NCT00830544 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
NCT00004906 ·Status: COMPLETED ·Phase: PHASE2
-
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
NCT04297384 ·Status: COMPLETED ·Phase: NA
-
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
NCT06800612 ·Status: RECRUITING
-
PrefeRences And ChemoTherapy In Breast Cancer patiEnts
NCT06332976 ·Status: RECRUITING
-
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
NCT00003095 ·Status: COMPLETED
-
Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
NCT01352494 ·Status: UNKNOWN ·Phase: PHASE2
-
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
NCT00003032 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function
NCT03062878 ·Status: COMPLETED
-
Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial
NCT00001250 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
NCT00038402 ·Status: COMPLETED ·Phase: PHASE3
-
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
NCT03983538 ·Status: COMPLETED
-
Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
NCT02338115 ·Status: COMPLETED
-
Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer
NCT01049425 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
NCT03493854 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Paclitaxel-Induced Neuropathy
NCT01953159 ·Status: ACTIVE_NOT_RECRUITING
-
CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
NCT04059003 ·Status: UNKNOWN
-
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer
NCT04081389 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response
NCT02214381 ·Status: COMPLETED ·Phase: PHASE3